Pulse Biosciences (PLSE) Net Income towards Common Stockholders (2021 - 2025)
Historic Net Income towards Common Stockholders for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to -$19.4 million.
- Pulse Biosciences' Net Income towards Common Stockholders fell 5272.87% to -$19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$74.7 million, marking a year-over-year decrease of 6195.35%. This contributed to the annual value of -$53.6 million for FY2024, which is 2694.86% down from last year.
- Per Pulse Biosciences' latest filing, its Net Income towards Common Stockholders stood at -$19.4 million for Q3 2025, which was down 5272.87% from -$19.2 million recorded in Q2 2025.
- Pulse Biosciences' Net Income towards Common Stockholders' 5-year high stood at -$9.2 million during Q4 2022, with a 5-year trough of -$19.4 million in Q4 2024.
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$14.0 million (2022), whereas its average is -$14.1 million.
- As far as peak fluctuations go, Pulse Biosciences' Net Income towards Common Stockholders surged by 4325.83% in 2023, and later tumbled by 6839.15% in 2025.
- Quarter analysis of 5 years shows Pulse Biosciences' Net Income towards Common Stockholders stood at -$15.4 million in 2021, then skyrocketed by 40.34% to -$9.2 million in 2022, then fell by 29.75% to -$11.9 million in 2023, then tumbled by 62.45% to -$19.4 million in 2024, then rose by 0.1% to -$19.4 million in 2025.
- Its Net Income towards Common Stockholders was -$19.4 million in Q3 2025, compared to -$19.2 million in Q2 2025 and -$16.8 million in Q1 2025.